Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Christopher von Jako
|
| gptkbp:FDAApproved |
gptkb:Major_Depressive_Disorder
Obsessive Compulsive Disorder |
| gptkbp:focusesOn |
neuropsychiatric disorders
|
| gptkbp:founded |
2003
|
| gptkbp:foundedBy |
Abraham Zangen
David Zacut Yiftach Roth |
| gptkbp:headquartersLocation |
gptkb:Jerusalem,_Israel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Brainsway
|
| gptkbp:industry |
medical devices
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:operatesIn |
gptkb:Europe
gptkb:Israel gptkb:United_States |
| gptkbp:product |
Deep TMS device
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
Deep Transcranial Magnetic Stimulation
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
BWAY
|
| gptkbp:website |
https://www.brainsway.com/
|
| gptkbp:bfsParent |
gptkb:הר_חוצבים
|
| gptkbp:bfsLayer |
6
|